Angela Raco

Angela Raco serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical countermeasures against infectious, immunologic, and allergic threats. She manages complex acquisitions for high-containment laboratory infrastructure, diagnostic platforms, and advanced analytical instrumentation critical to biosafety and outbreak response. Her work directly enables NIAID’s research readiness by securing mission-critical capabilities in biospecimen analysis, pathogen characterization, and biocontainment systems. Raco typically handles sole-source and competitive negotiated procurements under NIAID’s 75N930 authority, focusing on technical specifications aligned with federal biosafety level (BSL-3/4) requirements and Good Laboratory Practice (GLP) standards. Her primary contractor relationships center on Quality Biological, Inc., a leading supplier of reference materials and biological standards, and GENOMIC LABS LTD, a specialized provider of genomic sequencing and diagnostic reagents. These partnerships reflect a preference for vendors with proven expertise in high-integrity biological supply chains and regulatory-compliant manufacturing. Raco’s contracting approach emphasizes technical fidelity over volume, often engaging established suppliers with validated quality systems and biocontainment-certified production facilities. Raco’s procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects NIAID’s operational imperative to prioritize technical capability and supply chain reliability over socioeconomic classifications, particularly when procuring specialized biological and analytical systems with limited qualified vendors. Her industry focus is exclusively on NAICS 334516—Analytical Laboratory Instrument Manufacturing—encompassing next-generation sequencing platforms, mass spectrometers, real-time PCR systems, and automated biosafety cabinets. She procures highly engineered equipment requiring validation under ISO 13485 and FDA 21 CFR Part 820, ensuring compliance with federal biosurveillance and diagnostic research mandates. Her domain expertise lies at the intersection of laboratory automation, infectious disease diagnostics, and biocontainment technology.